J&J Saves Cidara’s Flu ‘Drug Cocktail’ From Pipeline Purge
Antibody Fragment Candidate To Progress
Executive Summary
Cidara Therapeutics has been given a lifeline after Johnson & Johnson’s opt-in on its universal flu prevention treatment – though the big pharma is expected to pass it onto a third party.